Kelendia Tablets 20mg, from Bayer Pharmaceutical, contain Finerenone, a non-steroidal mineralocorticoid receptor antagonist. With YJ code 2190044F2027 and a standard of 20mg per tablet, this medication is used for adults with chronic kidney disease (CKD) associated with type 2 diabetes to reduce the risk of kidney disease progression and cardiovascular events.
Kelendia Tablets 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →